ライフサイエンスコーパス: transglutaminase

1 lecular weight peptides were cross-linked by transglutaminase.

2 sign better substrates or inhibitors of this transglutaminase.

3 which then trigger the enzymatic activity of transglutaminase.

4 e fibrin network and cross-linking by plasma transglutaminase.

5 results from the polyamination of tubulin by transglutaminase.

6 that neuronal tubulin can be polyaminated by transglutaminase.

7 odification method involving thermolysin and transglutaminase.

8 followed by repolymerization with microbial transglutaminase.

9 l differences making FXIII unique from other transglutaminases.

10 n of antibodies against epidermal and tissue transglutaminases.

11 b, -2f, and -2g proteins), the cross-linking transglutaminase 1 enzyme (Tg-1) and Muc5AC mRNA transcr

12 ucocerebrosidase, acid sphingomyelinase, and transglutaminase 1.

13 ldren tested positive for IgA against tissue transglutaminase (1.0%; 95% confidence interval, 0.4%-1.

14 into the pathophysiology of TGM1 ichthyoses, transglutaminase-1 enzymatic activity, and potential the

15 sive, temperature-sensitive mutations in the transglutaminase-1 gene (TGM1).

16 , and anti-IgA autoantibodies against tissue transglutaminase (12%).

17 celiac disease or antibodies against tissue transglutaminase 2 (controls), healthy family members of

18 to both human Factor XIII (FXIII) and tissue transglutaminase 2 (hTG2).

19 isease (CD), a condition in which antitissue transglutaminase 2 (TG2) Abs are suspected to contribute

20 evious work in our laboratory has shown that transglutaminase 2 (TG2) acting as a coreceptor for inte

21 s of total IgA antibodies, IgA antibodies to transglutaminase 2 (TG2) and endomysium, as well as IgA

22 The interaction between the enzyme transglutaminase 2 (TG2) and fibronectin (FN) is involve

23 um domain of the fibronectin binding site on transglutaminase 2 (TG2) and its importance in mediating

24 Antibodies to the autoantigen transglutaminase 2 (TG2) are a hallmark of celiac diseas

25 Autoantibodies specific for the enzyme transglutaminase 2 (TG2) are a hallmark of the gluten-se

26 A plasma cells (PCs) specific for the enzyme transglutaminase 2 (TG2) are abundant in the small intes

27 Autoantibodies to transglutaminase 2 (TG2) are hallmarks of celiac disease

28 We and others have previously identified transglutaminase 2 (TG2) as a participant in adverse fib

29 Transglutaminase 2 (TG2) catalyzes transamidation or dea

30 Transglutaminase 2 (TG2) expression is required for epid

31 Tissue transglutaminase 2 (TG2) has been of particular interest

32 Molecular deletion of transglutaminase 2 (TG2) has been shown to improve funct

33 the autoantibody response against the enzyme transglutaminase 2 (TG2) in celiac disease patients by g

34 Genetic ablation of enzyme transglutaminase 2 (TG2) in Mgp(-/-) mice dramatically r

35 The mechanism of activation of transglutaminase 2 (TG2) in the extracellular matrix rem

36 e interferon-gamma (IFNgamma) and the enzyme transglutaminase 2 (TG2) in tissue destruction.

37 that it is a substrate for cross-linking by transglutaminase 2 (TG2) into higher-order species.

38 Transglutaminase 2 (TG2) is a Ca(2+)-dependent cross-lin

39 Tissue transglutaminase 2 (TG2) is a multifunctional protein pr

40 Transglutaminase 2 (TG2) is a ubiquitously expressed enz

41 Transglutaminase 2 (TG2) is a ubiquitously expressed enz

42 Transglutaminase 2 (TG2) is a ubiquitously expressed enz

43 Transglutaminase 2 (TG2) is secreted by a non-classical

44 The multifunctional, protein cross-linking transglutaminase 2 (TG2) is the main autoantigen in celi

45 The multifunctional enzyme transglutaminase 2 (TG2) is the target of autoantibodies

46 l commercial assays that measure IgA against transglutaminase 2 (TG2) or IgG against DGP.

47 e is presented in this study that shows that transglutaminase 2 (TG2) plays a critical role in the ad

48 For example, Trx activates extracellular transglutaminase 2 (TG2) via reduction of an intramolecu

49 ssion by interacting with its ligand, tissue transglutaminase 2 (TG2), but the molecular basis for th

50 aspase-3 activation through stabilization of transglutaminase 2 (TG2), which cross-links and inactiva

51 ion plasma cells (PCs), we have analyzed the transglutaminase 2 (TG2)-specific VH:VL autoantibody rep

52 odies reactive to gluten or the self-antigen transglutaminase 2 (TG2).

53 on of autoantibodies specific for the enzyme transglutaminase 2 (TG2).

54 cific for gluten peptides or the autoantigen transglutaminase 2 (TG2).

55 isfolded keratins; 2) elevated levels of the transglutaminase 2 (TG2); 3) increased K8 phosphorylatio

56 Interactions among IgA, CD71, and transglutaminase 2 (Tgase2) were analyzed by flow cytome

57 es the AP-1 transcription factor Fos and the transglutaminase 2 (TGase2), a cross-linking enzyme with

58 We identified transglutaminase 2 (TGM2) as a putative tumor suppressor

59 up 10 secretory phospholipase A2, Wnt5a, and transglutaminase 2 (Tgm2).

60 EMA-positive sera were further tested for transglutaminase 2 antibodies (TG2-IgA).

61 activation in different species and identify Transglutaminase 2 as a conserved M2 marker that is high

62 We demonstrate that tissue transglutaminase 2 can serotonylate histone H3 tri-methy

63 ERalpha as a direct regulator of macrophage transglutaminase 2 expression, a multifunctional atherop

64 Transglutaminase 2 has an affinity to the MUC2 CysD2 dom

65 patients, who have antibodies against tissue transglutaminase 2 in the absence of villous atrophy.

66 Transforming growth factor-beta and transglutaminase 2 stimulate Snail-dependent invadosome

67 e deposits (sCD89, transferrin receptor, and transglutaminase 2) decreased markedly 1 week after trea

68 rypsin (modified or unmodified by the enzyme transglutaminase 2) or the peptic-tryptic digest of glia

69 uced mesangial surface expression of TGase2 (transglutaminase 2), which in turn up-regulated TfR1 exp

70 l ECM, including the multi-functional enzyme transglutaminase 2, which we show is crucial for neuroge

71 infiltrating T cells, HLA-DR expression, and transglutaminase 2-targeted IgA deposits.

72 002-1E03 from a digest of gliadin treated by transglutaminase 2.

73 linical presentation (86%) and positive anti-transglutaminase 2/endomysium antibodies (99%) was obser

74 transition gene signature characteristic of transglutaminase 2/transforming growth factor-beta activ

75 tein keratin 8 (K8) and its cross-linking by transglutaminase-2 (TG2) are essential for MDB formation

76 Transglutaminase-2 (TG2) is a new anti-fibrotic target f

77 Transglutaminase-2 (TGM-2) has been implicated in severa

78 The stress protein transglutaminase-2 (TGM2) was also significantly higher

79 ell culture models, and this requires active transglutaminase-2 (TGM2).

80 Pep1 did not inhibit transglutaminase-2 activity, and incorporation of biotin

81 lts (for levels of antibodies against tissue transglutaminase-2 and deamidated gliadin peptide), symp

82 nct from the two CD hallmark antigens tissue transglutaminase-2 and deamidated gliadin, exhibiting 71

83 uired for MDB formation, including increased transglutaminase-2 and keratin overexpression, with a gr

84 Additionally, transglutaminase-2 expression was determined after YAP s

85 ysyl oxidase, lysyl oxidase-like 2-4, tissue transglutaminase-2), and ECM turnover genes/enzymes (mat

86 en fibrillar collagens, introduced by tissue transglutaminase-2, are necessary for the self-assembly

87 elastin and fibrillin can be cross-linked by transglutaminase-2, but the function of cross-linking on

88 tabilized by the matrix cross-linking enzyme transglutaminase-2.

89 Recently, a transglutaminase 3 knockout (TGM3/KO) mouse was generate

90 PADI3 (peptidylarginine deiminase 3), TGM3 (transglutaminase 3), and TCHH (trichohyalin) in a total

91 ibodies toward the newly identified neuronal transglutaminase 6 (TG6).

92 mutations in the TGM6 gene, which codes for transglutaminase 6 (TG6).

93 epidermal desmosomes, upregulated epidermal transglutaminase activity and heightened resistance to S

94 -out mice, led to a rapid rise in intestinal transglutaminase activity in a manner that could be inhi

95 Inhibiting polyamine synthesis or transglutaminase activity significantly decreases microt

96 Transglutaminase activity was increased in fibrosis, and

97 Transglutaminase addition exerted significant effect in

98 his study aimed to evaluate the influence of transglutaminase addition on the technological propertie

99 f a substrate, called Plugin, by the seminal transglutaminase AgTG3.

100 L.) (flour or seed) and cold gelling agents (transglutaminase, alginate or gelatin).

101 B (SS-A and SS-B, respectively), antitissue transglutaminase and antiendomysial antibodies, and para

102 LA-DQ8 genes) and autoantibodies (antitissue transglutaminase and antiendomysial).

103 These include elevated tissue transglutaminase and consequent inactivation through C-t

104 erologic tests for antibodies against tissue transglutaminase and deamidated gliadin peptide, greatly

105 f the profibrotic cleavage substrates tissue transglutaminase and endoglin accompanied MMP-14 suppres

106 esults of serum tests for IgA against tissue transglutaminase and endomysium or on both a health care

107 as well as for IgA antibodies against tissue transglutaminase and endomysium.

108 on-(gamma-glutamyl) lysine cross-linkages by transglutaminase and that enzymatic cross-linking increa

109 our antibody tests including IgA anti-tissue transglutaminase and/or IgA anti- endomysium permitted d

110 ults (IgA/IgG gliadin, endomysium, or tissue transglutaminase) and compared them with 213,208 age- an

111 bodies against gliadin, 1.22% against tissue transglutaminase, and 0.61% against endomysium (P>.05 vs

112 idase, gastric parietal cells (PCAs), tissue transglutaminase, and 21-hydroxylase was tested using a

113 g of VEGF165, catalysed by the enzyme tissue transglutaminase, and associates with MVs through its in

114 Concentrations of IgA, IgA antitissue transglutaminase, and endomysial antibodies were measure

115 anti-dpgli, IgG anti-dpgli, IgA anti- tissue transglutaminase, and IgA anti-endomysium) yielded posit

116 +SPI, WPI+CN and SPI+CN, were produced using transglutaminase, and their in vitro IgE reactivity and

117 high levels of autoantibodies against tissue transglutaminase (anti-TG2) are strongly indicative of a

118 years and analyzed for antibodies to tissue transglutaminase (anti-TG2A) using a radiobinding assay,

119 Serum samples were analyzed for anti-tissue transglutaminase (anti-tTG) concentrations at age 6 y.

120 between levels of antibodies against tissue transglutaminase (anti-tTG, a marker of celiac disease)

121 , antinuclear antibodies (ANAs), anti-tissue transglutaminase antibodies (AGTAs), and anti-thyroid pe

122 tive results from serologic tests for tissue transglutaminase antibodies (anti-TG2) but normal duoden

123 d optimized for determination of anti-tissue transglutaminase antibodies (anti-tTG) in human serum.

124 gneto immunosensor for the detection of anti-transglutaminase antibodies (ATG2) in celiac disease was

125 tive results from serologic tests for tissue transglutaminase antibodies (tTGA) without endoscopic de

126 ific screening serologic tests (anti- tissue transglutaminase antibodies IgA [anti-TTG] and ednomysea

127 Positivity for IgA tissue transglutaminase antibodies was detected in 97%.

128 itivities of Simtomax, endomysial and tissue-transglutaminase antibodies were compared in 133 prospec

129 Simultaneously, anti-tissue transglutaminase antibodies, questionnaire results, clin

130 It captures the target tissue transglutaminase antibody (anti-tTG), and finally allows

131 ning for celiac disease using the IgA tissue transglutaminase antibody (IgA tTG) and, if positive, te

132 ounger (P = .03), had lower titers of tissue transglutaminase antibody (P = .001), and less frequentl

133 The majority (98%) of FPs requested anti-transglutaminase antibody (tTG-Ab) titres for CD diagnos

134 ions revealed a slightly elevated IgA tissue transglutaminase antibody level in the setting of serum

135 Transglutaminases are also involved in fibrin(ogen) rete

136 n with lactoferrin and sodium alginate using transglutaminase as a cross-linking agent.

137 independent of coagulation factor 13 (FXIII) transglutaminase, as ANIT challenge in FXIII-deficient m

138 for up to 20 years for development of tissue transglutaminase autoantibodies (tTGA).

139 from birth were screened annually for tissue transglutaminase autoantibodies (tTGAs).

140 efined as being positive for islet or tissue transglutaminase autoantibodies at 2 consecutive clinic

141 ase autoimmunity, defined as positive tissue transglutaminase autoantibodies found in 2 consecutive s

142 Screening for celiac disease with tissue transglutaminase autoantibodies was performed annually i

143 Y study who were tested for islet and tissue transglutaminase autoantibodies, respectively.

144 bodies (HR, 0.99; 95% CI, 0.95-1.03), or the transglutaminase autoantibody (HR, 1.00; 95% CI, 0.98-1.

145 ntestinal biopsy or persistently high tissue transglutaminase autoantibody levels.

146 sults suggest that a risk of islet or tissue transglutaminase autoimmunity need not influence the rec

147 Through microbial transglutaminase-catalysed transamidation of gluten prot

148 Transglutaminases catalyze the covalent linkage of prote

149 cation of a disulfide bond and pH-controlled transglutaminase-catalyzed modification of lysine, respe

150 Endogenous brain transglutaminase-catalyzed polyaminated tubulins have th

151 Together, these findings suggest that transglutaminase-catalyzed polyamination of tubulins sta

152 Transglutaminase-catalyzed posttranslational incorporati

153 Moreover, we observed that the transglutaminase coagulation factor XIIIA (FXIIIA) was o

154 uggest that the proposed evolution of animal transglutaminase cross-linking activity from ancestral b

155 Dynamic rheometry indicated that transglutaminase cross-linking and niosomes charging of

156 Transglutaminase cross-linking prior to emulsification s

157 Here we show that transglutaminase cross-linking supports formation of a 1

158 techniques for monitoring the intramolecular transglutaminase cross-links of pea proteins, based on p

159 f 5.7 mum were fabricated and charged into a transglutaminase-cross-linked whey protein solution that

160 Transglutaminase crosslinked faba bean protein extensive

161 lf-assembled zein networks through microbial transglutaminase crosslinking were investigated.

162 elets stabilized FXIII-depleted thrombi in a transglutaminase-dependent manner.

163 of celiac disease is believed to involve the transglutaminase-dependent response of CD4(+) T cells to

164 Transglutaminase diseases: from biochemistry to the beds

165 Cyk3p possesses a transglutaminase domain that is essential for function,

166 Cross-linking the dialyzed emulsion with transglutaminase eliminated the detection of free lactas

167 beads (MBs) as a solid support in which the transglutaminase enzyme (TG2) is covalently immobilized

168 inocytes, produced TGM1 protein, and rescued transglutaminase enzyme function.

169 sed on the covalent immobilization of tissue transglutaminase enzyme in its open conformation (open-t

170 cornified envelope precursors and the tissue transglutaminase enzyme that cross-links them.

171 gelatin and gum arabic with or without using transglutaminase enzymes and to develop a functional kef

172 ion tomography/magnetic resonance imaging of transglutaminase factor XIII (FXIII) and myeloperoxidase

173 Coagulation transglutaminase factor XIII (FXIII) exists in circulati

174 nt study, we determined that activity of the transglutaminase factor XIII (FXIII) is critical for rbc

175 Here, we demonstrate that the coagulation transglutaminase, factor XIII (fXIII), drives arthritis

176 ogical importance of inactive members of the transglutaminase family, which are found throughout euka

177 Crosslinking with transglutaminase followed by freeze drying resulted in a

178 factor of 10 below the recommended amount of transglutaminase for raw as well as heated restructured

179 Transglutaminase from Streptomyces mobaraensis (MTG) is

180 faba bean protein isolates were treated with transglutaminase from Streptomyces mobaraensis and tyros

181 Using a gelatin microbial transglutaminase (gelatin-mTG) cell culture platform tun

182 hypothesised that the dosing of xylanase and transglutaminase has a positive impact on rye dough and

183 l cycle regulated and we unearth a bacterial transglutaminase homolog, HvyA, as restriction factor th

184 potency, and their selectivity toward other transglutaminase homologues is largely unknown.

185 Human tissue transglutaminase (hTG2) is a multifunctional enzyme.

186 Her positive anti-tissue transglutaminase IgA antibodies and ensuing duodenal bio

187 ts with concentrations of IgA against tissue transglutaminase (IgA-TTG) >10-fold the upper limit of n

188 tients should also be tested for anti-tissue transglutaminase, IgA against deamidated gliadin peptide

189 However, using the crosslinking enzyme Transglutaminase II to alter microstructure independentl

190 cient between the CDAT score and anti-tissue transglutaminase immunoglobulin A (anti-t-TG-IgA) titer

191 ion and diagnosis of CD, particularly tissue transglutaminase-immunoglobulin A (TG2-IgA), IgA testing

192 vidence for an increased risk of anti-tissue transglutaminase in patients with IBD vs controls (RR 1.

193 ibuted to glutamine deamidation by microbial transglutaminase in the absence of sufficient lysine thr

194 s have circulating antibodies against tissue transglutaminase; in children, European guidelines allow

195 assay using an assay for IgA against tissue transglutaminase; in subjects with positive test results

196 Transglutaminase increased the absolute zeta-potential v

197 All transglutaminases increased post-SNx peaking at loss of

198 vitro antioxidative hydrolysate, followed by transglutaminase-induced cross-linking and microemulsifi

199 ts into the mechanism and inhibition of this transglutaminase-induced ubiquitination by MavC, but als

200 Furthermore, treatment of mice with the pan-transglutaminase inhibitor cystamine resulted in signifi

201 I deficiency had normal retention, and a pan-transglutaminase inhibitor T101 had only a modest inhibi

202 encoding factor XIII subunit A (FXIII-A), a transglutaminase involved in hemostasis, wound healing,

203 here is no confirmation that TG2 is the only transglutaminase involved, neither there are strategies

204 Gluten deamidation by human tissue transglutaminase is critical to activate celiac disease

205 The dimeric FXIII-A(2), a pro-transglutaminase is the catalytic part of the heterotetr

206 In this study, we have profiled transglutaminase isozymes in the rat subtotal nephrectom

207 ins are previously undetected members of the transglutaminase-like cysteine protease superfamily, and

208 e diphosphate via its catalytically inactive transglutaminase-like domain.

209 We have identified a transglutaminase-like protein (Cyk3p) that functions in

210 Similar to canonical transglutaminases, MavC possess deamidase activity that

211 )-Lys92(Ube2N)) isopeptide crosslink using a transglutaminase mechanism.

212 observed ratio allowed the identification of transglutaminase-mediated gamma-glutamyl isomers as inte

213 rgenic protein products could be produced by transglutaminase-mediated heterologous polymerization of

214 terogeneous lysine conjugation and bacterial transglutaminase-mediated site-specific conjugation.

215 The transglutaminase-mediated, covalent cross-linking of pro

216 Microbial transglutaminase (mTG) catalyses the formation of protei

217 The substrate promiscuity of microbial transglutaminase (mTG) has been exploited in various app

218 Impacts of microbial transglutaminase (MTGase) (0-0.6 units/g sample) on gel

219 Key modifying roles of microbial transglutaminase (MTGase) in the development of innovati

220 Microbial transglutaminase (MTGase) is an enzyme of the class of t

221 ia sp. C1112 for the production of microbial transglutaminase (MTGase, EC 2.3.2.13).

222 Microbial transglutaminases (MTGs) catalyze the formation of Gln-L

223 general role for the catalytically inactive transglutaminases of fungi and animals, some of which ha

224 ) during storage in emulsion gels containing transglutaminase or alginate.

225 er limit of detection and IgG against tissue transglutaminase or deamidated gliadin peptide, or endom

226 Red rice cakes treated with transglutaminase presented a lower glucose release rate

227 Among tests for celiac disease, IgA tissue transglutaminase presented the best diagnostic test accu

228 has been indicated previously that during a transglutaminase reaction activated factor XIII (FXIIIa)

229 ng only the final deacylation portion of the transglutaminase reaction.

230 Analysis of heparin binding of the main transglutaminases revealed that although the interaction

231 The binding of SLPI with Cementoin to transglutaminase seems to be an effective strategy to tr

232 ic ATPase, anti-thyroid peroxidase, and anti-transglutaminase seropositivity, and these autoantibodie

233 use a proteomic approach in combination with transglutaminase-specific labeling to identify FXIIIa pl

234 lar methodologies to demonstrate that tissue transglutaminase (TG) activates downstream NF-kappaB sig

235 The popularity of transglutaminase (TG) by the food industry and the varia

236 In humans, 9 members of the transglutaminase (TG) family have been identified, of wh

237 -MS/MS-method for the detection of microbial transglutaminase (TG) from Streptomyces mobaraensis in d

238 for the simultaneous detection of microbial transglutaminase (TG) from Streptomyces mobaraensis, and

239 A2), cyclooxygenase 2 (COX-2), thrombin, and transglutaminase (TG).

240 ckpea protein (w/w) with/without addition of transglutaminase (TG).

241 Expression of the transglutaminase TG2 has been linked to constitutive act

242 The ubiquitous cross-linking enzyme tissue transglutaminase (TG2) has been implicated in irreversib

243 Tissue transglutaminase (TG2) is a multifunctional Ca(2+)-activ

244 Tissue transglutaminase (TG2) is a multifunctional enzyme invol

245 Type 2 transglutaminase (TG2) is an important cancer stem cell

246 ssion of the pro-inflammatory protein tissue transglutaminase (TG2) reprograms the transcription regu

247 inhibits melanoma growth and binds to tissue transglutaminase (TG2), a major crosslinking enzyme in E

248 Tissue transglutaminase (TG2), an enzyme involved in cell proli

249 tural GPR56 ligands, collagen III and tissue transglutaminase (TG2), and one small-molecule agonist,

250 performance of antibody tests against tissue transglutaminase (TG2), deamidated gliadin peptide (DGP)

251 ated with the sulfhydryl-rich protein tissue transglutaminase (TG2), thereby endowing the membrane su

252 ignificant increases in the levels of type-2 transglutaminase (TG2, which is implicated in transamida

253 nd levels of immunoglobulin A against tissue-transglutaminase (TGA-IgA) 10-fold or more the upper lim

254 nomer sample that had been cross-linked with transglutaminase (TGase) and digested with pepsin.

255 Extracellular transglutaminase (TGase) has been shown previously to pl

256 Transglutaminase (TGase) is a Ca(2+)-dependent cross-lin

257 Transglutaminase (TGase) is an enzyme for improving the

258 a milk base in the absence or presence of a transglutaminase (TGase) protein cross-linking step on t

259 atin hydrolysates and glucosamine (GlcN) via transglutaminase (TGase), as well as glycation between f

260 designed to detect the catalytic activity of transglutaminase (TGase), which creates a covalent bond

261 /50 degrees C) in the presence or absence of transglutaminase (TGase).

262 ll epitope through treatment with the enzyme transglutaminase (TGase).

263 Transglutaminases (TGases) are ubiquitous enzymes that t

264 evident 2 d after birth, followed by reduced transglutaminase (TGM) activity, transepidermal water lo

265 Transglutaminase (TGM)-2 has been shown to contribute to

266 in, angiopoietin-like factor (ANGPTL)-7, and transglutaminase (TGM)-2.

267 In vitro tissue transglutaminase (Tgm2) cross-linking was monitored and

268 By gene expression screening, tissue transglutaminase (TGM2) was identified as one of the gen

269 t extents on stiffer substrates; TAZ, tissue transglutaminase (TGM2), and soluble frizzled-related pr

270 ins (Krts), keratin-associated proteins, and transglutaminases (Tgms) and their substrates were signi

271 ormed by extensive cross-linking activity of transglutaminases (TGs) during terminal epidermal differ

272 We demonstrate that MavC is a transglutaminase that catalyses covalent linkage of ubiq

273 Coagulation factor XIIIa (FXIIIa) is a transglutaminase that covalently cross-links fibrin and

274 Plasma coagulation factor XIII (FXIII) is a transglutaminase that promotes cross-linking of the extr

275 Thus, unlike the active transglutaminases that activate RhoA, the multidomain pr

276 edicted after GC-1g, and the mean IgA-tissue transglutaminase titers declined, contrary to the predic

277 ne, TIG3 interacts with and activates type I transglutaminase to enhance keratinocyte terminal differ

278 lyacrylamide gel electrophoresis profiles of transglutaminase-treated low concentration (0.01% w/w) p

279 milar with known CD-specific antigens tissue transglutaminase (tTG) and deamidated gliadin, and the c

280 Immunoglobulin A (IgA) antibodies to tissue transglutaminase (tTG) are the serologic test of choice

281 Tissue transglutaminase (tTG) assay was available, but one-thir

282 Tissue transglutaminase (tTG) functions as a GTPase and an acyl

283 often relies on the presence of anti-tissue transglutaminase (tTG) IgA autoantibodies.

284 Tissue transglutaminase (tTG) is an acyltransferase/GTP-binding

285 ecognition scaffold is the following: tissue transglutaminase (tTG) is immobilized as a capturing age

286 glycated haemoglobin (HbA1c) and IgA tissue transglutaminase (tTg) were collected prior to, and foll

287 al antibodies (EMA) and antibodies to tissue transglutaminase (tTG) were developed to screen for celi

288 to different antigens, in particular tissue transglutaminase (tTG), gliadin (Glia), and endomysium.

289 ind the protein cross-linking enzyme, tissue transglutaminase (tTG), in cancer cell migration.

290 Tissue transglutaminase (tTG), involved in PTM of gluten antige

291 disease have serum antibodies against tissue transglutaminase (tTG).

292 such as increased antibody levels to tissue transglutaminase (tTG).

293 Transglutaminase type 2 (TG2) is an extracellular matrix

294 The positive predictive value of tissue transglutaminase type 2 (tTG) antibodies performed with

295 Rates of elevated levels of anti-transglutaminase type 2 and antigliadin antibodies were

296 Anti-transglutaminase type 2 and antigliadin antibodies were

297 re than 12000 participants) found IgA tissue transglutaminase was associated with high accuracy (sens

298 HLA DQ2/DQ8 and serum antibodies against transglutaminase were analysed.

299 Coagulation factor XIII (FXIII) is a transglutaminase with a well defined role in the final s

300 protein was crosslinked to some extent with transglutaminase with higher dosages (100 and 1000nkat/g